Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors

INTRODUCTION: This subgroup analysis assessed the efficacy and safety of once weekly dulaglutide 1.5 mg and 0.75 mg in East Asian patients with type 2 diabetes (T2D) stratified by key demographic and baseline characteristics. METHODS: Change from baseline in glycated hemoglobin (HbA1c), fasting bloo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetes Ther
Egile Nagusiak: Ma, Jianhua, Zhang, Bin, Hou, Jianing, Peng, Yongde
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7843818/
https://ncbi.nlm.nih.gov/pubmed/33161492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00955-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak